You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

Details for Patent: 4,158,055


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,158,055
Title: Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluor O-11.beta.,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate
Abstract:A method of treating topical inflammation in mammals by the administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluoro-11.beta.,21-dihy droxy-1,4-pregnadiene-3,20-dione 21-acetate in a pharmaceutically acceptable carrier.
Inventor(s): Shultz; Walter (Spring Valley, NY), Sieger; George M. (Montvale, NJ), Krieger; Charles (Clifton, NJ)
Assignee: American Cyanamid Company (Stamford, CT)
Application Number:05/754,917
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 4,158,055

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,158,055

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 7073674 ⤷  Sign Up
Belgium 818929 ⤷  Sign Up
Switzerland 601353 ⤷  Sign Up
Cyprus 946 ⤷  Sign Up
Germany 2437847 ⤷  Sign Up
France 2240738 ⤷  Sign Up
United Kingdom 1442925 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.